MIRA INFORM
REPORT
|
Report Date : |
08.06.2011 |
IDENTIFICATION DETAILS
|
Name : |
NABELIN CO LTD |
|
|
|
|
Registered Office : |
8-10 Futaba Matsumoto Nagano-Pref 390-8722 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.04.2011 |
|
|
|
|
Date of Incorporation : |
April 1948 |
|
|
|
|
Com. Reg. No.: |
(Nagano-Matsumoto) 013785 |
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
Line of Business : |
Import, Export, Wholesale of pharmaceuticals, chemicals, electronics,
foods |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Yen 1,492.0 Million, |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
---- |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Japan |
a1 |
a1 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company
name
NABELIN CO LTD
REGD NAME
Nabelin KK
MAIN OFFICE
8-10 Futaba Matsumoto
Nagano-Pref 390-8722
Tel:
0263-27-6545 Fax: 0263-25-1342
*.. Registered & Headquarters at: 3-2-27 Chuo Matsumoto Nagano-Pref
E-Mail address: nabelin.otoiawase@nabelin.co.jp
ACTIVITIES
Import,
export, wholesale of pharmaceuticals, chemicals, electronics, foods
BRANCHES
Tokyo,
Osaka, Nagano, Niigata, Okaya, other (Tot 25)
OVERSEAS
China,
Thailand, Taiwan, Philippines
OFFICERS
KAZUYOSHI
KURAI, PRES Hiroyuki Shima, s/mgn
dir
Kauris
Musha, s/mgn dir Kazutaka
Yamamoto, mgn dir
Takashi
Maruyama, dir Kazuya Oguchi,
dir
Yen
Amount: In million Yen, unless
otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 71,801 M
PAYMENTS REGULAR CAPITAL Yen 194 M
TREND SLOW WORTH Yen
9,001 M
STARTED 1948 EMPLOYES 511
COMMENT
TRADING FIRM SPECIALIZING IN
PHARMACEUTICALS, CHEMICALS, FOODS, OTHER.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
MAX CREDIT
LIMIT: YEN 1,492.0 MILLION, 30 DAYS NORMAL TERMS
HIGHLIGHTS
The subject company was established by Rinzo Shima as a wholesaler of
pharmaceuticals, on his account.
Incorporated in 1948, the firm has been succeeded by his
descendants. This is a trading firm for
import, export and wholesale of: pharmaceuticals, industrial chemicals, food
materials, electronic materials, other.
Has subsidiaries in China & Thailand, and sales offices in Taiwan
& Philippines. Clients include
hospitals, pharmaceutical makers, electronic makers, other, nationwide.
FINANCIAL INFORMATION
The sales volume for Apr2010 fiscal term amounted to Yen 71,801 million,
a 2% up from Yen 70,545 million in the previous term. Generic drugs and health foods were in good
demand. Exports also rose into Asian
markets. The recurring profit was posted
at Yen 606 million and the net profit at Yen 370 million, compared with Yen 265
million recurring profit and Yen 247 million net losses, respectively, a year
ago.
For the term that ended Apr 2011 the recurring profit was projected at
Yen 620 million and the net profit at Yen 380 million, respectively, on a 3%
rise in turnover, to Yen 74,000 million.
Final results are yet to be released.
The financial situation is considered FAIR and good for ORDINARY
business engagements. Max credit limit
is estimated at Yen 1,492.0 million, on 30 days normal terms.
REGISTRATION
Date Registered: Apr 1948
Regd No.: (Nagano-Matsumoto) 013785
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 7
million shares
Issued: 1.94 million shares
Sum: Yen 194 million
Major shareholders (%): Katabami KK (20.3), Nabelin
Pharmacy (7.3), Koichi Shima (6.4), other
No. of shareholders: 420
Nothing
detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Trading firm for
import, export and wholesale of: pharmaceuticals (ethical drugs, medical
equipment/materials (42%), industrial chemicals (basic chemicals, resins, other)
(32%), raw & processed food materials, food packaging materials, food
additives (17%), electronic materials, computer/equipment, other (5%), other
(4%).
Clients: [Mfrs,
wholesalers] Shinko Electric Inc, Nagano Red Cross Hospital, Shinshu Univ Hospital,
Seiko Epson, Kameda Seika Co, other
No. of accounts: 600
Domestic areas of
activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Takeda Chemicals in, Mitsui & Co, Daiichi Sankyo Co, Kyowa
Hakko Kirin Co, Nippon Soda Co, Astellas Pharma, Dainippon Sumitomo Pharma,
other
Payment record: Regular
Location: Business area in
Matsumoto, Nagano-Pref. Office premises
at the caption address are owned and maintained satisfactorily.
Bank References:
Mizuho
Bank (Matsumoto)
Hachijuni
Bank (Matsumoto)
Relations:
Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
30/04/2011 |
30/04/2010 |
30/04/2009 |
30/04/2008 |
|
|
Annual
Sales |
|
74,000 |
71,801 |
70,545 |
75,645 |
|
Recur.
Profit |
|
620 |
606 |
265 |
868 |
|
Net Profit |
|
380 |
370 |
247 |
431 |
|
Total
Assets |
|
|
34,255 |
31,033 |
35,161 |
|
Current
Assets |
|
|
26,850 |
23,958 |
|
|
Current
Liabs |
|
|
23,741 |
21,131 |
|
|
Net
Worth |
|
|
9,001 |
8,449 |
8,616 |
|
Capital,
Paid-Up |
|
|
194 |
194 |
194 |
|
Div.P.Share(¥) |
|
|
12.00 |
12.00 |
12.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.06 |
1.78 |
-6.74 |
-0.08 |
|
|
Current Ratio |
|
.. |
113.10 |
113.38 |
.. |
|
N.Worth Ratio |
.. |
26.28 |
27.23 |
24.50 |
|
|
R.Profit/Sales |
|
0.84 |
0.84 |
0.38 |
1.15 |
|
N.Profit/Sales |
0.51 |
0.52 |
0.35 |
0.57 |
|
|
Return On Equity |
.. |
4.11 |
2.92 |
5.00 |
|
Notes:
Forecast (or estimated) figures for the 30/04/2011 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.74 |
|
UK Pound |
1 |
Rs.73.25 |
|
Euro |
1 |
Rs.65.48 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.